<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link href="https://feeds.simplecast.com/glMRVVs2" rel="self" title="MP3 Audio" type="application/atom+xml"/>
    <atom:link href="https://simplecast.superfeedr.com/" rel="hub" xmlns="http://www.w3.org/2005/Atom"/>
    <generator>https://simplecast.com</generator>
    <title>The limbic (UK)</title>
    <description>Independent podcasts on a range of clinical and medico-political topics for specialists in the UK.</description>
    <copyright>2018-2020</copyright>
    <language>en</language>
    <pubDate>Fri, 19 Apr 2024 13:53:58 +0000</pubDate>
    <lastBuildDate>Fri, 19 Apr 2024 13:54:09 +0000</lastBuildDate>
    <image>
      <link>https://the-limbic.simplecast.com</link>
      <title>The limbic (UK)</title>
      <url>https://image.simplecastcdn.com/images/625cf068-4381-4a96-971a-7ccc5429c672/cf58bca6-8ebe-4988-9005-de1886804905/3000x3000/thelimbic-mark-black.jpg?aid=rss_feed</url>
    </image>
    <link>https://the-limbic.simplecast.com</link>
    <itunes:type>episodic</itunes:type>
    <itunes:summary>Independent podcasts on a range of clinical and medico-political topics for specialists in the UK.</itunes:summary>
    <itunes:author>The limbic</itunes:author>
    <itunes:explicit>false</itunes:explicit>
    <itunes:image href="https://image.simplecastcdn.com/images/625cf068-4381-4a96-971a-7ccc5429c672/cf58bca6-8ebe-4988-9005-de1886804905/3000x3000/thelimbic-mark-black.jpg?aid=rss_feed"/>
    <itunes:new-feed-url>https://feeds.simplecast.com/glMRVVs2</itunes:new-feed-url>
    <itunes:owner>
      <itunes:name>The limbic</itunes:name>
      <itunes:email>editor@thelimbic.com</itunes:email>
    </itunes:owner>
    <itunes:category text="Health &amp; Fitness">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <item>
      <guid isPermaLink="false">e8cc9aef-157c-4f53-8e73-0cad45156ad4</guid>
      <title>Breakfast at King&apos;s: Should colchicine prophylaxis be used with allopurinol for gout?</title>
      <description><![CDATA[Join us for Breakfast at King's - a series of discussions with experts at King's College London, hosted by Prof. James Galloway, on recent updates across the field of rheumatology!

In this episode, Dr Mark Russell discusses two recent papers looking at the use of colchicine prophylaxis for patients with gout when starting or escalating allopurinol doses. Dr Russell weighs up the benefits and risks of colchicine use, and discusses its potential in gout flare management.
]]></description>
      <pubDate>Fri, 19 Apr 2024 13:53:58 +0000</pubDate>
      <author>editor@thelimbic.com (The limbic)</author>
      <link>https://the-limbic.simplecast.com/episodes/breakfast-at-kings-should-colchicine-prophylaxis-be-used-with-allopurinol-for-gout-hD6PfEzw</link>
      <enclosure length="12272200" type="audio/mpeg" url="https://cdn.simplecast.com/audio/de162f1b-0e09-4b93-8e78-031ba7fce08d/episodes/0250e199-adc5-4e40-aa30-81d795fce6d4/audio/2c624fa5-1a77-4f22-9761-c44cded26827/default_tc.mp3?aid=rss_feed&amp;feed=glMRVVs2"/>
      <itunes:title>Breakfast at King&apos;s: Should colchicine prophylaxis be used with allopurinol for gout?</itunes:title>
      <itunes:author>The limbic</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/e7ce54e7-4eb8-49bf-87d3-38e0d3ede6c5/1c671bc3-6ea9-4994-8e14-1553353cf630/3000x3000/breakfast-at-king-s.jpg?aid=rss_feed"/>
      <itunes:duration>00:12:46</itunes:duration>
      <itunes:summary>Join us for Breakfast at King&apos;s - a series of discussions with experts at King&apos;s College London, hosted by Prof. James Galloway, on recent updates across the field of rheumatology!

In this episode, Dr Mark Russell discusses two recent papers looking at the use of colchicine prophylaxis for patients with gout when starting or escalating allopurinol doses. Dr Russell weighs up the benefits and risks of colchicine use, and discusses its potential in gout flare management.</itunes:summary>
      <itunes:subtitle>Join us for Breakfast at King&apos;s - a series of discussions with experts at King&apos;s College London, hosted by Prof. James Galloway, on recent updates across the field of rheumatology!

In this episode, Dr Mark Russell discusses two recent papers looking at the use of colchicine prophylaxis for patients with gout when starting or escalating allopurinol doses. Dr Russell weighs up the benefits and risks of colchicine use, and discusses its potential in gout flare management.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">04fdfdc2-e2ca-402a-89ad-e3b089570ec7</guid>
      <title>Breakfast at King&apos;s: The impact of antidrug antibodies on biologic treatments for RA</title>
      <description><![CDATA[Join us for Breakfast at King's hosted by Prof. James Galloway, a video series featuring updates in rheumatology with experts at King's College London.

In this episode, Dr Andrew Rutherford discusses the management of patients with rheumatoid arthritis and antidrug antibodies, who are being treated with biologics, including which biologic drugs have the highest risk of antidrug antibodies and whether methotrexate can reduce this risk.
]]></description>
      <pubDate>Wed, 20 Mar 2024 14:59:11 +0000</pubDate>
      <author>editor@thelimbic.com (The limbic)</author>
      <link>https://the-limbic.simplecast.com/episodes/breakfast-at-kings-the-impact-of-antidrug-antibodies-on-biologic-treatments-for-ra-KJhb6wEN</link>
      <enclosure length="11455100" type="audio/mpeg" url="https://cdn.simplecast.com/audio/de162f1b-0e09-4b93-8e78-031ba7fce08d/episodes/21268fca-c9c6-4219-bf91-55923e95eff0/audio/7543a2e8-3485-4041-b75d-f7f024f49d66/default_tc.mp3?aid=rss_feed&amp;feed=glMRVVs2"/>
      <itunes:title>Breakfast at King&apos;s: The impact of antidrug antibodies on biologic treatments for RA</itunes:title>
      <itunes:author>The limbic</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/e7ce54e7-4eb8-49bf-87d3-38e0d3ede6c5/218e4c8f-0451-4ce9-94b9-b68d49cc68fd/3000x3000/breakfast-at-king-s.jpg?aid=rss_feed"/>
      <itunes:duration>00:11:55</itunes:duration>
      <itunes:summary>Join us for Breakfast at King&apos;s hosted by Prof. James Galloway, a video series featuring updates in rheumatology with experts at King&apos;s College London.

In this episode, Dr Andrew Rutherford discusses the management of patients with rheumatoid arthritis and antidrug antibodies, who are being treated with biologics, including which biologic drugs have the highest risk of antidrug antibodies and whether methotrexate can reduce this risk.</itunes:summary>
      <itunes:subtitle>Join us for Breakfast at King&apos;s hosted by Prof. James Galloway, a video series featuring updates in rheumatology with experts at King&apos;s College London.

In this episode, Dr Andrew Rutherford discusses the management of patients with rheumatoid arthritis and antidrug antibodies, who are being treated with biologics, including which biologic drugs have the highest risk of antidrug antibodies and whether methotrexate can reduce this risk.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>5</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">cd1845b4-2c66-446e-8137-4d2b36f760b8</guid>
      <title>Breakfast at King&apos;s: CAR-T therapy in lupus</title>
      <description><![CDATA[Join us for Breakfast at King's - a series of discussions with experts at King's College London, hosted by Prof. James Galloway, on recent updates across the field of rheumatology!

In this episode, Dr Chris Wincup discusses a published case series that highlights the potential for CAR T-cell therapy for patients with autoimmune disease. He also describes the long and durable responses being seen with CAR-T cell therapy, hospitalisation requirements for those undergoing therapy, and specific safety considerations (including CRS and ICANS).
]]></description>
      <pubDate>Fri, 8 Mar 2024 08:01:34 +0000</pubDate>
      <author>editor@thelimbic.com (The limbic)</author>
      <link>https://the-limbic.simplecast.com/episodes/breakfast-at-kings-car-t-therapy-in-lupus-7H9t7R9o</link>
      <enclosure length="16369872" type="audio/mpeg" url="https://cdn.simplecast.com/audio/de162f1b-0e09-4b93-8e78-031ba7fce08d/episodes/87055d4d-98ba-4b20-b126-2efd246369ef/audio/3945560a-1bad-45ea-ab49-fd856a256fdd/default_tc.mp3?aid=rss_feed&amp;feed=glMRVVs2"/>
      <itunes:title>Breakfast at King&apos;s: CAR-T therapy in lupus</itunes:title>
      <itunes:author>The limbic</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/e7ce54e7-4eb8-49bf-87d3-38e0d3ede6c5/96f4df40-b774-4a0c-af7a-2d7cd7e60c4f/3000x3000/breakfast-at-king-s.jpg?aid=rss_feed"/>
      <itunes:duration>00:17:02</itunes:duration>
      <itunes:summary>Join us for Breakfast at King&apos;s - a series of discussions with experts at King&apos;s College London, hosted by Prof. James Galloway, on recent updates across the field of rheumatology!

In this episode, Dr Chris Wincup discusses a published case series that highlights the potential for CAR T-cell therapy for patients with autoimmune disease. He also describes the long and durable responses being seen with CAR-T cell therapy, hospitalisation requirements for those undergoing therapy, and specific safety considerations (including CRS and ICANS).</itunes:summary>
      <itunes:subtitle>Join us for Breakfast at King&apos;s - a series of discussions with experts at King&apos;s College London, hosted by Prof. James Galloway, on recent updates across the field of rheumatology!

In this episode, Dr Chris Wincup discusses a published case series that highlights the potential for CAR T-cell therapy for patients with autoimmune disease. He also describes the long and durable responses being seen with CAR-T cell therapy, hospitalisation requirements for those undergoing therapy, and specific safety considerations (including CRS and ICANS).</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">18d5e049-0038-4c5a-97b0-223580bb5a61</guid>
      <title>CAR T in the real world: Efficacy and safety</title>
      <description><![CDATA[In this final episode of our CAR-T update series, Dr Robin Sanderson, consultant haematologist at Kings College Hospital in London, talks about the efficacy and toxicity data presented at US and European meetings this year. As more real-world evidence is gathered, how is this moving the therapy forward.
]]></description>
      <pubDate>Mon, 23 Oct 2023 01:09:53 +0000</pubDate>
      <author>editor@thelimbic.com (The limbic)</author>
      <link>https://the-limbic.simplecast.com/episodes/car-t-in-the-real-world-efficacy-and-safety-O2lNf5rK</link>
      <enclosure length="15670381" type="audio/mpeg" url="https://cdn.simplecast.com/audio/de162f1b-0e09-4b93-8e78-031ba7fce08d/episodes/7adf294d-b1de-40a6-9160-b03648f67800/audio/6c42bd69-c0d6-4326-b07c-f9820fa0a911/default_tc.mp3?aid=rss_feed&amp;feed=glMRVVs2"/>
      <itunes:title>CAR T in the real world: Efficacy and safety</itunes:title>
      <itunes:author>The limbic</itunes:author>
      <itunes:duration>00:16:19</itunes:duration>
      <itunes:summary>In this final episode of our CAR-T update series, Dr Robin Sanderson, consultant haematologist at Kings College Hospital in London, talks about the efficacy and toxicity data presented at US and European meetings this year. As more real-world evidence is gathered, how is this moving the therapy forward.</itunes:summary>
      <itunes:subtitle>In this final episode of our CAR-T update series, Dr Robin Sanderson, consultant haematologist at Kings College Hospital in London, talks about the efficacy and toxicity data presented at US and European meetings this year. As more real-world evidence is gathered, how is this moving the therapy forward.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1aca0dc2-c17c-452c-9200-63f8b60f4924</guid>
      <title>CAR T in the real world: More centres coming on board</title>
      <description><![CDATA[In the second of three episodes, Dr Graham Collins, consultant haematologist in Oxford, discusses how they prepared to infuse their first patient and what is happening with the wider rollout of CAR T therapies to other NHS centres.
]]></description>
      <pubDate>Mon, 16 Oct 2023 04:09:26 +0000</pubDate>
      <author>editor@thelimbic.com (The limbic)</author>
      <link>https://the-limbic.simplecast.com/episodes/car-t-in-the-real-world-more-centres-coming-on-board-gueTZOaJ</link>
      <enclosure length="15126612" type="audio/mpeg" url="https://cdn.simplecast.com/audio/de162f1b-0e09-4b93-8e78-031ba7fce08d/episodes/7a400a5a-b71c-4556-8ebb-02d3d928964b/audio/112cd7e8-79ae-423f-83a6-19bab970dd27/default_tc.mp3?aid=rss_feed&amp;feed=glMRVVs2"/>
      <itunes:title>CAR T in the real world: More centres coming on board</itunes:title>
      <itunes:author>The limbic</itunes:author>
      <itunes:duration>00:15:45</itunes:duration>
      <itunes:summary>In the second of three episodes, Dr Graham Collins, consultant haematologist in Oxford, discusses how they prepared to infuse their first patient and what is happening with the wider rollout of CAR T therapies to other NHS centres.</itunes:summary>
      <itunes:subtitle>In the second of three episodes, Dr Graham Collins, consultant haematologist in Oxford, discusses how they prepared to infuse their first patient and what is happening with the wider rollout of CAR T therapies to other NHS centres.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">bf27bdc5-2e77-455a-88fd-897710c3868e</guid>
      <title>CAR T in the real world: New indications</title>
      <description><![CDATA[In this first episode, Dr Maeve O’Reilly, a consultant haematologist at University College Hospital London, takes us through new approvals and indications of CAR T and what to expect next.
]]></description>
      <pubDate>Wed, 4 Oct 2023 02:38:45 +0000</pubDate>
      <author>editor@thelimbic.com (The limbic)</author>
      <link>https://the-limbic.simplecast.com/episodes/car-t-in-the-real-world-new-indications-b7_iCtYU</link>
      <enclosure length="15654078" type="audio/mpeg" url="https://cdn.simplecast.com/audio/de162f1b-0e09-4b93-8e78-031ba7fce08d/episodes/262c6ab5-7010-4b62-aa7d-000d7d2169a7/audio/2a19ad47-6989-4288-8ffd-c26805b3e0a3/default_tc.mp3?aid=rss_feed&amp;feed=glMRVVs2"/>
      <itunes:title>CAR T in the real world: New indications</itunes:title>
      <itunes:author>The limbic</itunes:author>
      <itunes:duration>00:16:17</itunes:duration>
      <itunes:summary>In this first episode, Dr Maeve O’Reilly, a consultant haematologist at University College Hospital London, takes us through new approvals and indications of CAR T and what to expect next.</itunes:summary>
      <itunes:subtitle>In this first episode, Dr Maeve O’Reilly, a consultant haematologist at University College Hospital London, takes us through new approvals and indications of CAR T and what to expect next.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">730b2a0c-6383-4c40-99bb-a9d943f8ae4e</guid>
      <title>Supportive care in haemato-oncology: Psychosocial support and palliative care</title>
      <description><![CDATA[Sarah Henshaw, myeloma clinical nurse specialist at Nottingham University Hospitals and Dr Jennifer Vidrine, consultant in palliative and supportive care medicine at Newcastle Hospitals NHS Foundation Trust discuss what psychosocial support patients may need at different points in their care, advance care planning, when to refer to palliative care teams and how teams can best work together in the interest of the patient.
]]></description>
      <pubDate>Sun, 27 Aug 2023 23:15:47 +0000</pubDate>
      <author>editor@thelimbic.com (The limbic)</author>
      <link>https://the-limbic.simplecast.com/episodes/supportive-care-in-haemato-oncology-psychosocial-support-and-palliative-care-Wx3l4hDP</link>
      <enclosure length="28974850" type="audio/mpeg" url="https://cdn.simplecast.com/audio/de162f1b-0e09-4b93-8e78-031ba7fce08d/episodes/bac744cc-64fc-475c-977a-3718c16aade1/audio/f1deb990-f539-44a9-ac9c-c558b4d7fc10/default_tc.mp3?aid=rss_feed&amp;feed=glMRVVs2"/>
      <itunes:title>Supportive care in haemato-oncology: Psychosocial support and palliative care</itunes:title>
      <itunes:author>The limbic</itunes:author>
      <itunes:duration>00:30:10</itunes:duration>
      <itunes:summary>Sarah Henshaw, myeloma clinical nurse specialist at Nottingham University Hospitals and Dr Jennifer Vidrine, consultant in palliative and supportive care medicine at Newcastle Hospitals NHS Foundation Trust discuss what psychosocial support patients may need at different points in their care, advance care planning, when to refer to palliative care teams and how teams can best work together in the interest of the patient.</itunes:summary>
      <itunes:subtitle>Sarah Henshaw, myeloma clinical nurse specialist at Nottingham University Hospitals and Dr Jennifer Vidrine, consultant in palliative and supportive care medicine at Newcastle Hospitals NHS Foundation Trust discuss what psychosocial support patients may need at different points in their care, advance care planning, when to refer to palliative care teams and how teams can best work together in the interest of the patient.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>4</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">131100fb-6bbe-4359-8ff5-6ba427dc398d</guid>
      <title>Supportive care in haemato-oncology: Treatment toxicities</title>
      <description><![CDATA[Professor Gordon Cook, professor of haematology at the University of Leeds and lead for the myeloma clinical and translational research portfolio and Professor Graham Jackson, consultant haematologist at Newcastle upon Tyne Hospitals NHS Foundation Trust discuss managing toxicities associated with treatment including peripheral neuropathies, cytopenias, cytokine release syndrome and ICANs, as well as cardiac and gastrointestinal complications.
]]></description>
      <pubDate>Tue, 22 Aug 2023 05:57:21 +0000</pubDate>
      <author>editor@thelimbic.com (The limbic)</author>
      <link>https://the-limbic.simplecast.com/episodes/supportive-care-in-haemato-oncology-treatment-toxicities-sFDKSriE</link>
      <enclosure length="26954433" type="audio/mpeg" url="https://cdn.simplecast.com/audio/de162f1b-0e09-4b93-8e78-031ba7fce08d/episodes/f338e743-3715-4ccf-85a1-3ac40343d4e9/audio/68578f67-b945-43cb-bcd3-f4e7559a9d92/default_tc.mp3?aid=rss_feed&amp;feed=glMRVVs2"/>
      <itunes:title>Supportive care in haemato-oncology: Treatment toxicities</itunes:title>
      <itunes:author>The limbic</itunes:author>
      <itunes:duration>00:28:04</itunes:duration>
      <itunes:summary>Professor Gordon Cook, professor of haematology at the University of Leeds and lead for the myeloma clinical and translational research portfolio and Professor Graham Jackson, consultant haematologist at Newcastle upon Tyne Hospitals NHS Foundation Trust discuss managing toxicities associated with treatment including peripheral neuropathies, cytopenias, cytokine release syndrome and ICANs, as well as cardiac and gastrointestinal complications.</itunes:summary>
      <itunes:subtitle>Professor Gordon Cook, professor of haematology at the University of Leeds and lead for the myeloma clinical and translational research portfolio and Professor Graham Jackson, consultant haematologist at Newcastle upon Tyne Hospitals NHS Foundation Trust discuss managing toxicities associated with treatment including peripheral neuropathies, cytopenias, cytokine release syndrome and ICANs, as well as cardiac and gastrointestinal complications.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f4790cd0-9597-42bf-8b2f-30a6cebd5f2a</guid>
      <title>Supportive care in haemato-oncology: Managing and preventing infection</title>
      <description><![CDATA[Professor Gordon Cook, professor of haematology at the University of Leeds and lead for the myeloma clinical and translational research portfolio and Professor Graham Jackson, consultant haematologist at Newcastle upon Tyne Hospitals NHS Foundation Trust discuss managing and preventing infection in blood cancer patients, including prophylaxis, vaccination, Covid and more.
]]></description>
      <pubDate>Fri, 18 Aug 2023 11:15:18 +0000</pubDate>
      <author>editor@thelimbic.com (The limbic)</author>
      <link>https://the-limbic.simplecast.com/episodes/supportive-care-in-haemato-oncology-managing-and-preventing-infection-z334sUcu</link>
      <enclosure length="28695124" type="audio/mpeg" url="https://cdn.simplecast.com/audio/de162f1b-0e09-4b93-8e78-031ba7fce08d/episodes/81d77885-be32-4ce6-810d-9c4d2d195c19/audio/b4e2f605-4415-4518-99d7-12f93626ef14/default_tc.mp3?aid=rss_feed&amp;feed=glMRVVs2"/>
      <itunes:title>Supportive care in haemato-oncology: Managing and preventing infection</itunes:title>
      <itunes:author>The limbic</itunes:author>
      <itunes:duration>00:29:53</itunes:duration>
      <itunes:summary>Professor Gordon Cook, professor of haematology at the University of Leeds and lead for the myeloma clinical and translational research portfolio and Professor Graham Jackson, consultant haematologist at Newcastle upon Tyne Hospitals NHS Foundation Trust discuss managing and preventing infection in blood cancer patients, including prophylaxis, vaccination, Covid and more.</itunes:summary>
      <itunes:subtitle>Professor Gordon Cook, professor of haematology at the University of Leeds and lead for the myeloma clinical and translational research portfolio and Professor Graham Jackson, consultant haematologist at Newcastle upon Tyne Hospitals NHS Foundation Trust discuss managing and preventing infection in blood cancer patients, including prophylaxis, vaccination, Covid and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d4b54c92-c45d-4b5a-ab2f-44e77a988e8e</guid>
      <title>Supportive care in haemato-oncology: An overview</title>
      <description><![CDATA[Michelle Kenyon, consultant nurse in BMT at Kings College Hospital NHS Foundation Trust, and Dr Stella Bowcock, consultant haematologist interested in myeloma and supportive care, also based at Kings College Hospital NHS Foundation Trust, discuss the pillars of supportive care in haematology-oncology, what is unique about the needs of this group of patients, communication and co-ordination of care throughout the patient journey.
]]></description>
      <pubDate>Fri, 18 Aug 2023 11:15:04 +0000</pubDate>
      <author>editor@thelimbic.com (The limbic)</author>
      <link>https://the-limbic.simplecast.com/episodes/supportive-care-in-haemato-oncology-an-overview-sKIbpls3</link>
      <enclosure length="28192737" type="audio/mpeg" url="https://cdn.simplecast.com/audio/de162f1b-0e09-4b93-8e78-031ba7fce08d/episodes/d3d64bea-16a0-466d-9031-8563e97d46e1/audio/4d7467b0-6c62-4637-87a1-7fe62bbac398/default_tc.mp3?aid=rss_feed&amp;feed=glMRVVs2"/>
      <itunes:title>Supportive care in haemato-oncology: An overview</itunes:title>
      <itunes:author>The limbic</itunes:author>
      <itunes:duration>00:29:22</itunes:duration>
      <itunes:summary>Michelle Kenyon, consultant nurse in BMT at Kings College Hospital NHS Foundation Trust, and Dr Stella Bowcock, consultant haematologist interested in myeloma and supportive care, also based at Kings College Hospital NHS Foundation Trust, discuss the pillars of supportive care in haematology-oncology, what is unique about the needs of this group of patients, communication and co-ordination of care throughout the patient journey.</itunes:summary>
      <itunes:subtitle>Michelle Kenyon, consultant nurse in BMT at Kings College Hospital NHS Foundation Trust, and Dr Stella Bowcock, consultant haematologist interested in myeloma and supportive care, also based at Kings College Hospital NHS Foundation Trust, discuss the pillars of supportive care in haematology-oncology, what is unique about the needs of this group of patients, communication and co-ordination of care throughout the patient journey.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ed79b758-036c-4de6-b599-122c405ffefb</guid>
      <title>Are medical students prepared for the realities of life on NHS wards?</title>
      <description><![CDATA[A recent BMA survey suggested that four in ten junior doctors are planning to quit as soon as they find another job. It is clear doctors are under immense pressure and facing increasing rates of burnout. With this in mind, how well are we preparing new doctors for managing the cognitive, psychological, and emotional challenges of their work? In this podcast, we speak to Dr Luke Austen whose new book, The Bleep Test, uses his personal experience and the published evidence to answer these questions. He also provides practical tips for new doctors on breaking bad news, prioritising tasks, learning from mistakes and being civil to colleagues.
]]></description>
      <pubDate>Tue, 27 Jun 2023 14:43:58 +0000</pubDate>
      <author>editor@thelimbic.com (The limbic)</author>
      <link>https://the-limbic.simplecast.com/episodes/are-medical-students-prepared-for-realities-of-life-on-nhs-wards-4HGdRmcD</link>
      <enclosure length="18630001" type="audio/mpeg" url="https://cdn.simplecast.com/audio/de162f1b-0e09-4b93-8e78-031ba7fce08d/episodes/cb01b48a-8582-4a3a-9687-b7a0a58cb48f/audio/ebd364ff-89a7-4d9f-9d50-f89693ea0d37/default_tc.mp3?aid=rss_feed&amp;feed=glMRVVs2"/>
      <itunes:title>Are medical students prepared for the realities of life on NHS wards?</itunes:title>
      <itunes:author>The limbic</itunes:author>
      <itunes:duration>00:19:23</itunes:duration>
      <itunes:summary>A recent BMA survey suggested that four in ten junior doctors are planning to quit as soon as they find another job. It is clear doctors are under immense pressure and facing increasing rates of burnout. With this in mind, how well are we preparing new doctors for managing the cognitive, psychological, and emotional challenges of their work? In this podcast, we speak to Dr Luke Austen whose new book, The Bleep Test, uses his personal experience and the published evidence to answer these questions. He also provides practical tips for new doctors on breaking bad news, prioritising tasks, learning from mistakes and being civil to colleagues.</itunes:summary>
      <itunes:subtitle>A recent BMA survey suggested that four in ten junior doctors are planning to quit as soon as they find another job. It is clear doctors are under immense pressure and facing increasing rates of burnout. With this in mind, how well are we preparing new doctors for managing the cognitive, psychological, and emotional challenges of their work? In this podcast, we speak to Dr Luke Austen whose new book, The Bleep Test, uses his personal experience and the published evidence to answer these questions. He also provides practical tips for new doctors on breaking bad news, prioritising tasks, learning from mistakes and being civil to colleagues.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">bd8f0833-475b-41ce-a8e4-0eb8384c5fec</guid>
      <title>CAR-T in the UK: What’s next</title>
      <description><![CDATA[
]]></description>
      <pubDate>Fri, 27 May 2022 04:17:42 +0000</pubDate>
      <author>editor@thelimbic.com (The limbic)</author>
      <link>https://the-limbic.simplecast.com/episodes/car-t-in-the-uk-whats-next-LlFdx9Xe</link>
      <enclosure length="28488260" type="audio/mpeg" url="https://cdn.simplecast.com/audio/de162f1b-0e09-4b93-8e78-031ba7fce08d/episodes/9ad05bfd-4dbe-4531-903c-31fe454d60a2/audio/d726fe0e-50e3-4983-bb60-79401217c0a8/default_tc.mp3?aid=rss_feed&amp;feed=glMRVVs2"/>
      <itunes:title>CAR-T in the UK: What’s next</itunes:title>
      <itunes:author>The limbic</itunes:author>
      <itunes:duration>00:29:40</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">44cdbf7e-be3a-49fc-ba6b-8ccc7292ab97</guid>
      <title>CAR-T in the UK: A unique roll out</title>
      <description><![CDATA[
]]></description>
      <pubDate>Fri, 27 May 2022 04:07:41 +0000</pubDate>
      <author>editor@thelimbic.com (The limbic)</author>
      <link>https://the-limbic.simplecast.com/episodes/car-t-in-the-uk-a-unique-roll-out-p12V7Jxq</link>
      <enclosure length="33098350" type="audio/mpeg" url="https://cdn.simplecast.com/audio/de162f1b-0e09-4b93-8e78-031ba7fce08d/episodes/1aecbb6b-ebe3-41fd-a101-3cae2f5150b8/audio/7d4fdc1d-2fb6-4a35-94be-12f9a1afbf13/default_tc.mp3?aid=rss_feed&amp;feed=glMRVVs2"/>
      <itunes:title>CAR-T in the UK: A unique roll out</itunes:title>
      <itunes:author>The limbic</itunes:author>
      <itunes:duration>00:34:28</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
    </item>
  </channel>
</rss>